Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Ciardiello, F. ; Normanno, N. ; Martinelli, E. ; Troiani, T. ; Pisconti, S. ; Cardone, C. ; Nappi, A. ; Bordonaro, A.R. ; Rachiglio, M. ; Lambiase, M. ; Latiano, T.P. ; Modoni, G. ; Cordio, S. ; Giuliani, F. ; Biglietto, M. ; Montesarchio, V. ; Barone, C. ; Tonini, G. ; Cinieri, S. ; Febbraro, A. ; Rizzi, D. ; De Vita, F. ; Orditura, M. ; Colucci, G. ; Maiello, E. ; Iaffaioli, Vincenzo ; Nasti, Guglielmo ; Botti, Gerardo ; Tatangelo, F. ; Chicchinelli, Nicoletta ; Montrone, Mirko ; Sebastio, Annamaria ; Guarino, Tiziana ; Simone, Gianni ; Graziano, Paolo ; Chiarazzo, Cinzia ; Di Maggio, Gabriele ; Longhitano, Laura ; Manusia, Mario ; Cartenì, Giacomo ; Nappi, Oscar ; Micheli, Pietro ; Leo, Luigi ; Rossi, Sabrina ; Cassano, Alessandra ; Tommaselli, Eugenio ; Giordano, Guido ; Sponziello, Francesco ; Marino, Antonella ; Rinaldi, Antonio ; Romito, Sante ; Muda, Andrea Onetti ; Lorusso, Vito ; Leo, Silvana ; Barni, Sandro ; Grimaldi, Giuseppe ; Aieta, Michele

England: Elsevier Ltd

Full text available

European Consensus Conference for external quality assessment in molecular pathology

van Krieken, J.H. ; Siebers, A.G. ; Normanno, N. ; Blackhall, F. ; Boone, E. ; Botti, G. ; Carneiro, F. ; Celik, I. ; Ciardiello, F. ; Magrassi, F. ; Lanzara, A. ; Cree, I.A. ; Deans, Z.C. ; Dequeker, E. ; Edsjö, A. ; Groenen, P.J.T.A. ; Kamarainen, O. ; Kreipe, H.H. ; van Krieken, J.H. ; Ligtenberg, M.J.L. ; Marchetti, A. ; Murray, S. ; Normanno, N. ; Opdam, F.J.M. ; Patterson, S.D. ; Patton, S. ; Pinto, C. ; Rouleau, E. ; Schuuring, E. ; Siebers, A.G. ; Sterck, S. ; Taron, M. ; Tejpar, S. ; Timens, W. ; Thunnissen, E. ; van de Ven, P.M.

Oxford: Elsevier Ltd

Full text available

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial

Ciardiello, F. ; Normanno, N. ; Maiello, E. ; Martinelli, E. ; Troiani, T. ; Pisconti, S. ; Giuliani, F. ; Barone, C. ; Cartenì, G. ; Rachiglio, A.M. ; Montesarchio, V. ; Tonini, G. ; Rizzi, D. ; Cinieri, S. ; Bordonaro, R. ; Febbraro, A. ; De Vita, F. ; Orditura, M. ; Fenizia, F. ; Lambiase, M. ; Rinaldi, A. ; Tatangelo, F. ; Botti, G. ; Colucci, G.

Oxford: Elsevier Ltd

Full text available

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

Normanno, N. ; Rachiglio, A.M. ; Lambiase, M. ; Martinelli, E. ; Fenizia, F. ; Esposito, C. ; Roma, C. ; Troiani, T. ; Rizzi, D. ; Tatangelo, F. ; Botti, G. ; Maiello, E. ; Colucci, G. ; Ciardiello, F. ; Giuliani, F. ; Simone, G. ; Febbraro, A. ; Tommaselli, E. ; Cinieri, S. ; Criscuolo, M. ; Perrino, A. ; Rinaldi, A. ; Bordonaro, R. ; Manusia, M. ; Romito, S. ; Bufo, P. ; Cartenì, G. ; Biglietto, M. ; Nappi, O. ; Cardarelli, A. ; Montesarchio, E. ; Micheli, P. ; Nasti, G. ; Chicchinelli, N. ; Iannaccone, A. ; Russo, A. ; Cabibi, D. ; Giaccone, P. ; Barone, C. ; Rindi, G. ; Tonini, G. ; Onetti Muda, A. ; Perrone, G. ; Latiano, T. ; Graziano, P. ; Pisconti, S. ; Sebastio, A.

England: Elsevier Ltd

Full text available

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort

Barba, M. ; Sperati, F. ; Stranges, S. ; Carlomagno, C. ; Nasti, G. ; Iaffaioli, V. ; Caolo, G. ; Mottolese, M. ; Botti, G. ; Terrenato, I. ; Vici, P. ; Serpico, D. ; Giordano, A. ; D’Aiuto, G. ; Crispo, A. ; Montella, M. ; Capurso, G. ; Delle Fave, G. ; Fuhrman, B. ; Botti, C. ; De Placido, S.

Oxford: Elsevier Ltd

Full text available

1969P The SGLT2 inhibitor dapagliflozin enhanced anticancer activities and exerts cardioprotective effects against doxorubicin and trastuzumab toxicity through TLR4, MyD88, NF-kB signaling and NLRP3 inflammasome pathway

Maurea, N. ; Quagliariello, V. ; Bonelli, A. ; Caronna, A. ; Grimaldi, I. ; Lombari, C. ; Conforti, G. ; Botti, G.

Elsevier Ltd

Full text available

1944P Hyperglycemia increased nivolumab-induced cardiotoxicity, enhanced immunoresistance of ERɑ+, PR+, HER2- breast cancer cells modulating growth factors and NLRP3 expression

Quagliariello, V. ; Bonelli, A. ; Caronna, A. ; Lombari, C. ; Grimaldi, I. ; Conforti, G. ; Botti, G. ; Maurea, N.

Elsevier Ltd

Full text available

Cardioprotective and anti-inflammatory effects of empagliflozin during treatment with doxorubicin: A cellular and preclinical study

Quagliariello, V. ; Coppola, C. ; Rea, D. ; Maurea, C. ; Barbieri, A. ; Botti, G. ; Maurea, N.

Full text available

1894P - Cardioprotective and anti-inflammatory effects of empagliflozin during treatment with doxorubicin: A cellular and preclinical study

Quagliariello, V. ; Coppola, C. ; Rea, D. ; Maurea, C. ; Barbieri, A. ; Botti, G. ; Maurea, N.

Elsevier Ltd

Full text available

Phase I/II study of valproic acid (VPA) and short-course radiotherapy (SCRT) plus capecitabine (CAP) as preoperative treatment in low-moderate risk rectal cancer (V-shoRT-R3)

Budillon, A ; Delrio, P ; Pecori, B ; Tatangelo, F ; Di Gennaro, E ; Romano, C ; D'Angelo, V ; Marone, P ; Granata, C ; Cavalacanti, E ; De Stefano, A ; Pace, U ; Bianco, F ; Petrillo, A ; Lastoria, S ; Botti, G ; Muto, P ; Perrone, F ; Piccirillo, M C ; Avallone, A

England

Full text available